Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

A

Agilent Technologies (A)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:A
DataOraFonteTitoloSimboloCompagnia
19/12/202419:45Business WireAgilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:AAgilent Technologies
13/12/202415:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:AAgilent Technologies
10/12/202417:09Business WireAgilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR CertificationNYSE:AAgilent Technologies
04/12/202400:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AAgilent Technologies
26/11/202416:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:AAgilent Technologies
25/11/202422:05Business WireAgilent Reports Fourth-Quarter Fiscal Year 2024 Financial ResultsNYSE:AAgilent Technologies
25/11/202415:01Business WireAgilent Announces New Organizational Structure to Support its Market-Focused StrategyNYSE:AAgilent Technologies
20/11/202422:05Business WireAgilent Increases Cash Dividend to 24.8 Cents per ShareNYSE:AAgilent Technologies
20/11/202414:00Business WireAgilent 2024 Early Career Professor Award Presented to Adeyemi AdeleyeNYSE:AAgilent Technologies
19/11/202422:29Business WireAgilent Ranks No. 11 on Fortune’s List of Best Workplaces in the WorldNYSE:AAgilent Technologies
14/11/202414:00Business WireAgilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial ResearchNYSE:AAgilent Technologies
06/11/202414:00Business WireAgilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California ScientistsNYSE:AAgilent Technologies
21/10/202408:00Business WireAgilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC SeriesNYSE:AAgilent Technologies
16/10/202422:30Business WireAgilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25NYSE:AAgilent Technologies
30/09/202423:17Business WireAgilent to Host Analyst and Investor Day on Dec. 17, 2024NYSE:AAgilent Technologies
27/09/202418:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AAgilent Technologies
20/09/202417:01Business WireAgilent Completes Acquisition of BIOVECTRANYSE:AAgilent Technologies
18/09/202422:20Business WireAgilent Announces Cash Dividend of 23.6 Cents per ShareNYSE:AAgilent Technologies
09/09/202414:00Business WireAgilent Unveils Biopharma CDx Services Lab to Accelerate Precision MedicineNYSE:AAgilent Technologies
05/09/202400:18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:AAgilent Technologies
04/09/202414:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:AAgilent Technologies
03/09/202415:12Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:AAgilent Technologies
22/08/202411:37IH Market NewsSchwab and Snowflake Retreat in Premarket, WeRide Postpones IPO, Halliburton Cyberattack, McDonald’s Instagram HackNYSE:AAgilent Technologies
21/08/202422:05Business WireAgilent Reports Third-Quarter Fiscal Year 2024 Financial ResultsNYSE:AAgilent Technologies
15/08/202414:00Business WireAgilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph PerformanceNYSE:AAgilent Technologies
02/08/202414:00Business WireAgilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell TherapyNYSE:AAgilent Technologies
29/07/202415:55Business WireAgilent Acquires Sigsense, Creator of AI-Enabled Lab Operations TechnologyNYSE:AAgilent Technologies
23/07/202412:00IH Market NewsJohnson Controls Division Sold for $8 Billion; Alphabet’s Offer Rejected by Wiz; AMD President Announces RetirementNYSE:AAgilent Technologies
22/07/202422:33Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:AAgilent Technologies
22/07/202415:01Business WireAgilent to Acquire North American CDMO BIOVECTRANYSE:AAgilent Technologies
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:A
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network